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RESUMO.- [Anestesia total intravenosa com propofol-
quetamina racêmica e propofol quetamina-S: estudo
comparativo e avaliação hemodinâmica em cães sub-
metidos à ovariohisterectomia.] A anestesia total intra-
venosa (TIVA) com propofol e quetamina proporciona um
efeito muito satisfatório do ponto de vista clínico. Este es-
tudo, cego e randomizado, comparou a indução e manu-
tenção da anestesia com infusão contínua de propofol-
quetamina racêmica (PRK) e propofol-quetamina-S (PSK)
em cães, e avaliou seus efeitos hemodinâmicos, metabó-
licos e ventilatórios. Foram avaliadas sete cadelas em
cada grupo, submetidas à ovariohisterectomia. A anestesia
foi induzida no Grupo PRK, com propofol (4.0mg kg-1) e
cetamina (2.0mg kg-1) por via intravenosa (i.v.), seguida
de infusão contínua de propofol (dose inicial de 0.5mg kg-
1 min-1) e cetamina racêmica(0.2mg kg-1 min-1) i.v. No Gru-
po PSK, a indução anestésica foi com propofol (4.0mg kg-
1) e cetamina-S (1.0 mg kg-1) i.v., seguida  de infusão con-
tínua de propofol (dose inicial de 0,5mg kg-1 min-1) e
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Total intravenous anaesthesia (TIVA) with propofol and ketamine proved to be very
satisfactory from a clinical point of view. This blind randomised controlled trial was designed
to compare induction and maintenance of anaesthesia under continuous infusion of
propofol-racemic ketamine (PRK) with that of propofol-S-ketamine (PSK) and evaluate
their haemodynamic, metabolic and ventilatory effects. Seven female dogs undergoing
ovariohysterectomy were involved in each group. Anaesthesia was induced: in Group
PRK, with propofol (4.0mg kg-1) and racemic ketamine (2.0mg kg-1) intravenous (i.v.),
followed by i.v. infusion of propofol (initial dose of 0.5mg kg-1 min-1) and racemic ketamine
(0.2mg kg-1 min-1); in Group PSK, with propofol (4.0mg kg-1) and S-ketamine (1.0 mg kg1)
i.v., followed by i.v. infusion of propofol (initial dose of 0.5mg kg-1 min-1) and S-ketamine
(0.1mg kg-1 min-1). Parameters were assessed before anaesthesia and in 6 time points
after induction. In both groups, heart rate increased significantly at all time points. There
was a slight decrease in systemic blood pressure, cardiac output and cardiac index in
both groups. The systolic index decrease significantly and intense respiratory depression
was observed in all groups, making assisted ventilation necessary.
INDEX TERMS:  Anaesthesia, haemodynamic, propofol, ketamine, dog.
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cetamina-S ( 0.1mg kg-1 min-1) i.v. Os parâmetros foram
observados antes da anestesia e em seis momentos após
a indução anestésica.
Em ambos os grupos, a freqüência cardíaca elevou-
se significantemente em todos os momentos. Houve pe-
quena redução na pressão arterial sistêmica, débito car-
díaco e índice cardíaco. O índice sistólico apresentou re-
dução significante e houve intensa depressão respirató-
ria em ambos os grupos. A anestesia total intravenosa
com a associação do propofol à cetamina racêmica ou à
cetamina-S proporciona boa estabilidade hemodinâmica,
entretanto, há intensa depressão respiratória, havendo
necessidade de assistência ventilatória.
TERMOS DE INDEXAÇÃO: Anestesia, hemodinâmica, propofol,
cetamina, cão.
INTRODUCTION
Propofol produces its anaesthetic effect by acting at GABA
receptors (Stoelting 1999). Propofol pharmacokinetic
properties contribute to its rapid clearance from the body
(Nolan & Reid 1993).  The anaesthetic and side effects of
propofol are largely dose-related, and it would be therefore
advantageous to combine propofol with other anaesthetic
agents in order to decrease the dose, and minimize these
adverse effects.
The hypnotic and anaesthetic actions of ketamine are
thought to be via N-methyl-D-aspartate (NMDA) receptors
(Mayer & Miller 1990).  NMDA antagonism results in
blockage of spinal nociceptive reflexes (Hara et al. 1993),
by blocking the conduction of painful impulses to the
thalamus and to areas of the cortex (White et al. 1982).
Furthermore, there is an interaction with the opioid
receptors μ and sigma (James et al. 1984; Parsons et al.
1998), the muscarinic receptors and the calcium channels
(Hirota & Lambert 1996).
Blockage of NMDA receptors with low doses of
ketamine is desirable for a good analgesic effect (Ryder
et al. 1978). This analgesic effect is due to reduction of
nociceptives  reflections of the spinal medulla (Kitahata et
al. 1973) that are otherwise activated in response to pain.
Hemelrijck & White (1997) studies have shown that
S(+)-ketamine is potent in binding to N-methyl-D-aspartate
(NMDA) opioid receptors and efficient in blocking NMDA
and acetylcholine induced neuronal currents.
In man, S(+)Ketamine has an anaesthetic-analgesic
effect two to four times greater than racemic ketamine
(White et al. 1985; Mathisen et al. 1995; Lauretti et al.
2000), and its hyptonic effect is more potent than that of
the R(-) isomer (Terra et al. 1999), allowing the use of
lower doses of S(+) ketamine compared to racemic
ketamine.
In man, total intravenous anaesthesia (TIVA) with
propofol and ketamine proved to be very satisfactory from
a clinical point of view (Schüttler et al. 1991). This
combination allows a reduction in the hypnotic dose of
propofol and a decrease in the cardiovascular depression
induced by this drug (Badrinath et al. 2000). According to
Schüttler et al. (1991) the major side effects of propofol
(reduced haemodynamics during induction) and ketamine
(psychic disturbances and cardiovascular stimulation) were
absent and respiratory function post-surgery was ade-
quate. However, a study by Loh & Dalen (2007) using the
ketamine-propofol combination in humans, showed that
some patients experienced significant hemodynamic and
respiratory compromise, highlighting the need for further
research on the use of this drug combination for routine
sedation and analgesia.
To this end, we wish to compare the induction and
maintenance of anaesthesia under continuous infusion of
propofol-racemic ketamine with that of propofol-S-ketamine
in female dogs undergoing ovariohysterectomy and evalu-
ate their haemodynamic, metabolic and ventilatory effects.
MATERIALS AND METHODS
The study was approved by the Ethics Committee for the Analysis
of Research Projects of the Hospital das Clínicas and of the
School of Medicine, University of São Paulo. A comparative
double-blind randomized study design was evaluated. Seven
healthy female mongrel dogs, aged 1 to 5 years, weighing 13.7
±1.9 kg were evaluated in each group in this investigation. Health
status was based on physical examination, complete blood
count, biochemical profile and blood gases.
Food was withheld from all animals for 12 and water for 4
hours prior to the beginning of the study. No premedication
was used. To allow an adequate instrumentation, anaesthesia
was induced with isoflurane (Forane, Abbott, São Paulo,
Brazil) delivered by face-mask and carried in 50% oxygen at
a flow rate of 1 L minute–1. When jaw relaxation was adequate
the trachea was intubated (Magill, Rusch, Kernen, Germany).
The endotracheal tube was connected to a rebreathing circuit
(Cicero, Dräguer, Lübeck, Germany). Dogs were placed in
dorsal recumbence and maintained at one MAC of isoflurane
(1.4%). An anaesthetic agent analyser (Anaesthetic Gas
Analyser and Capnograph, Criticare Systems INC, Wisconsin,
USA) was used to determine isoflurane end expiratory
concentration and end-tidal CO2 concentration. Oxygen
saturation, rectal temperature and the eletrocardiogram were
measured continuously (Viridia, Model 66S, Hewlett
Packard, Boeblingen, Germany). The cephalic veins were
canulated with a polyethylene 20 SWG catheter (Insyte,
Becton Dickenson, Juiz de Fora, Brazil) and, during the
entire procedure, lactated Ringer’s solution was adminis-
tered at an infusion rate of 10ml kg-1 hour-1 (Ringer Lactate
Solution, Baxter, São Paulo, Brazil).
The femoral vein and artery were dissecated to allow
introduction of the pulmonary artery catheter (Swan Ganz
Thermodilution Catheter Model 744H-7.5F, Baxter Healthcare
Corporation, CA, USA) and of an arterial cannula for systemic
arterial pressure monitoring respectively. Local anaesthesia
with 2% lignocaine (7.0mg kg-1) (Xylestesin; Cristália, São
Paulo, Brazil) was performed to provide adequate analge-
sia.
The dogs were placed in right lateral recumbency for
recovery of the inhalatory anaesthesia. Sixty minutes after the
suspension of inhalatory anaesthesia, baseline haemodynamics
parameters were collected (heart rate; systolic, diastolic and
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mean arterial pressure; mean pulmonary arterial pressure;
wedge pressure, central venous pressure and cardiac output).
Other variables such as cardiac index, stroke index, systemic
vascular resistance index and pulmonary vascular resistance
index were calculated by the computer. Arterial blood and mixed
venous samples were collected from femoral artery and from
pulmonary artery catheter for pH, blood gases, bicarbonate,
oxygen saturation, electrolytes and lactate evaluation in a blood
gas analyzer (ABL blood gas analyzer; Radiometer, Cope-
nhagen, Denmark).
The bitchs were then randomly divided into two groups:
- Group propofol-racemic ketamine (PRK): induction of
anaesthesia was performed with propofol (4.0mg kg-1) plus racemic
ketamine (2.0mg kg-1) also administered i.v. slowly in a single bolus,
immediately followed by i.v. infusion of propofol (initial dose of 0.5mg
kg-1 min-1) and racemic ketamine (0.2mg kg-1 min-1);
- Group propofol-S(+)ketamine (PSK): induction of anaesthesia
was performed with propofol (4.0mg kg-1) and S-ketamine (1.0mg kg-
1) administered i.v. and maintained by continuous infusion of propofol
(initial dose of 0,5mg kg-1 min-1) and S-ketamine ( 0.1mg kg-1 min-1).
After the animals became recumbent, the trachea was
intubated. Separate infusion pumps (Infusion Pump-670,
Santronic, São Paulo, Brazil) were used for different drugs and
the dogs anaesthetized for ovariohysterectomy, performed
always by the same surgeon.
In both groups, the maintenance doses of propofol were
given based on its effect. The doses were elevated or reduced
under alterations of heart rate and systolic blood pressure.
Whenever heart rate and systolic blood pressure increased by
20%, a bolus injection of 20% of induction dose of propofol
was given and infusion rates were increased by 20% over the
previous value, waiting 3 minutes before resuming surgery.
The quality of induction was evaluated using clinical criteria
and expressed as good (good muscle relaxation, easy
intubation and no jaw tone), intermediate (poor muscle
relaxation, difficult intubation) or poor (excitability and
impossible intubation). Induction time was defined as the period
beginning with anaesthetics administration and ending when
the trachea was intubated. Orotracheal intubation and the
anaesthetic evaluation were performed by the same observer.
The animals were initially maintained on spontaneous
ventilation, with assisted ventilation introduced when ETCO2
values reached 45 mmHg. A respiratory rate of 10-15 breaths
minute-1, a tidal volume of 10ml kg-1 with a peak inspiratory
pressure of 15cm H2O and a FiO2 of 0.5 were used after
induction.
The parameters were assessed immediately before induction
of anaesthesia (baseline or M1), five minutes after (M2), at the
time of skin incision (M3), at the time of the ovarian pedicle
clamping (M4), at the time of suture of the abdominal wall (M5)
and thirty minutes after the end of infusion (M6).
Recovery times (tracheal extubation, head lift and sternal
recumbency unaided) were measured from the time the infusion
was switched off.
Results were expressed as mean values (±SD). A one-way
ANOVA with repeated measures, followed by the Tukey’s test
was used to analyze changes in the physiologic and calculated
parameters between different observation times (GraphPad
InStat, version 3.01, San Diego, CA, USA). For between-group
comparisons, Unpaired’s t-test was used. The level of signifi-
cance established was 5% (p<0.05).
RESULTS
Induction of anaesthesia was good in all animals. In groups
PRK and PSK the maintenance mean doses of propofol
were slightly increased in relation to the initial doses, 14%
and 28.5%, respectively (Table 1). Time of drug infusion
was 65.5 (± 11.4) minutes for group PRK and 67.8 (± 14.0)
minutes for group PSK.
Fig.1. Changes in cardiac rate of animals included in the two
experimental protocols at different assessment time points;
# PSK differs significantly from PRK (p<0.05). M1 or baseline,
immediately before the induction of anaesthesia; M2, at 5
minutes of infusion; M3, at the time of skin incision; M4, at
the time of the ovarian pedicle clamping; M5, at the time of
suture of the abdominal wall; M6, 30 minutes after the end
of infusion.
Table 1. The mean values and standard deviations (±SD)
for doses of propofol (mg kg-1 min-1) combined with 0.2
mg kg-1 min- of  racemic ketamine (PRK, n=7) and
combined with 0.1 mg kg-1 min- S-ketamine (PSK, n=7) at
the different assessment time points
Groups At 5 minutes Skin incision Pedicle Suture of
of infusion clamping  abdominal
wall
Propofol PSK 0.5±0 0.40±0.12 0.43±0.11 0.37±0.10
(mg kg-1 PRK 0.5±0 0.41±0.16 0.49±0.21 0.41±0.16
min-1)
During maintenance of anesthesia, heart rate increased
significantly in both groups and in all anaesthetic time points
in relation to the baseline (M1). In group PRK the increase
was equivalent to 68% and in group PSK, 54% at five
minutes after induction (M2); at the time of skin incision
(M3) the increase was 68% in Group PRK, and 58% in Group
PSK; at the time of the ovarian pedicle clamping (M4) the
increase was 50% in Group PRK and PSK in relation to M1
(Table 2, Fig.1) in relation to M1. The Group PSK showed
significant increased values then Group PRK at thirty
minutes after the end of infusion (M6) (Table 2).
In both groups, systolic arterial blood pressure (SAP)
showed stable values close to those of baseline. Diastolic
arterial blood pressure (DAP) values in Group PRK were
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stable and close to the baseline. In group PSK, DAP values
increased slightly after thirty minutes of the end of infusion
(M6) (Table 2). In both groups, mean arterial blood pres-
sure (MAP) values were stable, close to baseline, with a
slight increase at the time of ovarian pedicle clamping (M4)
and thirty minutes after the end of infusion (M6) (Table 2).
The Group PSK showed slight increased values then
Group PRK, in M6.
Cardiac index (CI) alterations were not observed in both
groups. A significant reduction in systolic index (SI) oc-
curred in the two studied groups. In group PRK, a 50%
reduction occurred in M2 and was maintained until M5. In
PSK the reduction was 41% in M2 reaching up to 45% in
M5 (Table 2).
Both groups showed increase in systemic vascular
resistance index (SVRI) especially at the time of ovarian
pedicle clamping (M4) (Table 1).
There was intense respiratory depression following
induction at the beginning of infusion of the drugs in the
both groups, with animals returning to spontaneous
ventilation only after all anaesthetics infusions were
stopped. A slight increase in carbon dioxide pressure on
the arterial blood due to respiratory depression was
observed, leading to respiratory acidosis with significant
reduction of arterial blood pH values (Table 3).
PSK animals showed faster recovery, with earlier
extubation time, quicker head-up and shorten sternal
recumbency duration (Table 4). At that time, all animals
Table 3. Mean values (±SD) of the arterial blood gases of the dogs treated with propofol-racemic
ketamine (PRK) and propofol-S-ketamine (PSK) at the different assessment time points
Parameters Groups Baseline At 5 minutes Skin incision Pedicle Suture of At 30 minutes
of infusion clamping abdominal wall of recovery
Respiratory Rate PRK 20.14±7.6 11.7±7.1 14.00±10.3 9.71±3.9 13.86±3.5 28.57±16.4
 (breaths minute-1) PSK 22.86±8.0 11.9±3.5 11.29±4.6 13.43±5.8 13.29±5.7 30.29±4.6
PaO2 PRK 98.8±8.2 402.2±44.9 426.2±17.7 446.0±16.1 435.8±20.9 89.7±8.7
(mm Hg) PSK 96.1±9.8 407.5±37.0 426.2±48.9 405.5±89.1 411.5±65.4 87.7±10.4
PaCO2 PRK 32.7±1.8 48.8
*±6.4 47.1*±8.9 48.0*±7.3 48.4*±5.2 43.2±10.7
(mm Hg) PSK 31.7±2.1 47.5*±3.7 53.4*±7.7 53.1*±7.6 48.2*±4.1 41.5*±5.1
pH PRK 7.38±0.04 7.25*±0.03 7.27*±0.06 7.24*±0.04 7.25*±0.04 7.32±0.04
PSK 7.39±0.02 7.29*±0.05 7.26*±0.05 7.25*±0.04 7.28*±0.05 7.35±0.05
* p<0.05, significant difference in relation to baseline value.
Table 2. The mean values (±SD) for direct and calculated haemodynamic parameters of the dogs
treated with propofol-racemic ketamine (PRK) and propofol-S-ketamine (PSK) at the different
assessment time points
Parameters Groups Baseline At 5 minutes Skin incision Pedicle Suture of At 30 minutes
of infusion clamping abdominal wall of recovery
HR PRK 100±14.2 168*#±23.2 167*±26.2 150*±25.0 149*±23.0 151*±28.6
(beats min-1) PSK 99±14.4 152*±29.0 158*±28.4 158*±25.6 149*±24.1 187*#±24.6
SAP PRK 154±27.7 142±27.0 139±30.4 150±35,5 131±22.7 185*±25.3
(mm Hg) PSK 164±21.6 138±16.9 141±16.3 167±13.4 136±27.9 150±32.8
DAP PRK 93±14.8 93±20.1 95±19.0 110±24.4 95±16.2 108±22.2
(mm Hg) PSK 96±15.4 95±18.6 96±19.9 119±16.7 96±19.4 127±15.2
MAP PRK 116±19.2 111±21.1 111±21.6 121±24.0 109± 9.6 123±24.6
(mm Hg) PSK 121±6.2 111±17.5 111±15.9 135±15.1 108±18.9 145±16.9
PAP (M) PRK 15.7±2.1 15.2±1.8 15.7 ± 2.9 16.4±3.9 15.4±2.5 13.7±3.5
(mm Hg) PSK 14.4±3.4 14.5±2.3 15.1±2.8 15.8±3.0 14.1±1.7 15.1±2.1
PAOP PRK 6.7±2.0 6.7±1.8 8.7±2.0 8.1±2.3 8.2±1.7 6.0±1.9
(mm Hg) PSK 5.4±0.9 6.5±1.2 7.1±2.9 8.5±2.1 7.4 ±1.62 5.8±2.4
CVP PRK 4.7±0.9 5.5±0.9 7.2±1.9 8.4±1.2 6.8±1.7 6.1±2.0
(mm Hg) PSK 4.7±2.2 5.0±1.6 5.5±3.2 6.2±3.4 4.5±2.7 5.1*±3.0
CI PRK 4.57±0.78 3.80±0.55 3.91±0.89 3.38±1.00 3.36± .10 4.18±1.41
(L min-1 m-2) PSK 3.98±0.83 3.47±0.95 3.81±0.97 4.02±0.75 3.23±0.86 5.25±1.34
SI PRK 45.6±2.8 22.8*±3.8 23.9*±6.9 23.4*±9.7 23.1*±8.8 27.2±7.4
(ml m-2 bat-2) PSK 40.5±8.59 23.5*±7.6 24.9*±8.0 26.3*±7.8 22.0*±7.0 28.2*±7.3
SVRI PRK 1933±365 2209±518 2181±573 2544±341 2599±726 2422±748
(dina seg cm-5 m-2) PSK 2299±311 2278±477 2208±622 2519±383 2608±413 2269±608
PVRI PRK 147±30 159±17 137±61 163±64 177±45 136±43
(dina seg cm-5 m-2) PSK 139±78 162±42 160±41 128±37 167±61 155±34
* p<0.05, significant difference in relation to baseline value; # p<0.05, significant difference in relation to the other group; HR,
Heart rate; SAP = systolic arterial blood pressure; DAP = diastolic arterial blood pressure; MAP = mean arterial blood pres-
sure; PAP = pulmonary artery pressure; PAOP = pulmonary artery occlusion pressure; CVP = central venous pressure; CI =
cardiac index; SI = systolic index; SVRI = systemic vascular resistance index; PVRI = pulmonary vascular resistance index.
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received 2mg/kg of tramadol cloridrate i.m. for adequate
post surgery analgesia.
DISCUSSION
The aim of this study was to evaluate and compare the
induction and maintenance of anaesthesia under TIVA of
propofol and S(+)ketamine with that of  propofol and
racemic ketamine. We asked if the benefits of S(+)ke-
tamine reported for other species (Ryder et al. 1978, White
et al. 1985, Pfenninger et al. 2002, Strümper et al. 2004)
regarding its clinically apparent potency, overall quality of
anesthesia and decreased undesirable effects, would have
a synergistic effect when associated to propofol.
Premedications as well as different degrees of surgical
stimulus and the concurrent use of other drugs may
complicate comparison of different anaesthetic drugs both
at combined administration.
The combination of ketamine and propofol has been
used in anaesthesia induction in dogs (Lerche et al. 2000)
and in man, with good clinical and anaesthetic results
(Mayer et al. 1990, Guit et al. 1991, Palermo et al. 1991,
Schüttler et al. 1991, Hérnandez et al. 1999). This combi-
nation showed a positive synergistic effect when compared
to both drugs alone. Propofol with racemic ketamine or S-
ketamine in TIVA allowed a reduction of 50 to 60% in the
doses when compared to single administration (Hui et
al.1995, Watkins et al. 1987, Mannarino 2002).
In man, S(+)Ketamine has an anaesthetic-analgesic
effect two to four times greater than racemic ketamine
(White et al. 1985, Mathisen et al. 1995, Lauretti et al.
2000), and its hyptonic effect is more potent than that of
the R(-) isomer (Terra et al. 1999), witch allows the use of
lower doses of S(+) ketamine when compared to racemic
ketamine. Rossetti et al. (2008) observed in stallions
undergoing castration, a higher analgesic effect of S(+)-
ketamine, which was represented by a more stable
physiologic parameters during the procedure and also a
lower anesthetic requirement.
Our results show that propofol combined with both
ketamines for TIVA promotes good surgical conditions with
no evisceration and good relaxation. Nevertheless the PSK
group required an extra dose of propofol when compared
to the PRK group during surgical procedure, indicating
lower dose efficiency of the drugs.
Induction and maintenance of anaesthesia with propofol
during various surgical procedures in man led to reduction
in heart rate and arterial blood pressure (Scarrone et al.
1990, Hui et al. 1995). Propofol decreases arterial blood
pressure by decreasing peripheral vascular resistance and
myocardial contractility (Gauss et al. 1991, Pagel & Warltier
1993). According to some authors, propofol promotes
decrease in cardiac output (Maneglia & Cousin 1988,
Goodchild & Serrao 1989) and increase in heart rate to
compensate the decrease in arterial blood pressure (Hall
& Chambers 1987, Claeys et al. 1988).  On the other hand,
anaesthesia with ketamine produces an excessive
sympathomimetic action with increases the heart rate and
arterial blood pressure (White et al. 1980), as well as a
dose-related increase in the rate-pressure product with a
transient increase in the cardiac index but no alteration in
the stroke index (Tweed et al. 1972, Idvall et al. 1979).
After administration of racemic or S(+) ketamine in
equianalgesic doses, identical and significant increases
in plasma cathecolamines, arterial blood pressure and
heart rate are observed (Adams et al. 1992, Adams 1997).
In our study similar results were observed, with arterial
blood pressure and heart rate showing approximate values
in both groups. Despite no occurrence of cardiac index
alteration a significant reduction in the systolic index as
well as an increase in systemic vascular resistance index
was observed in both groups. A good equilibrium between
the cardiostimulating effects of ketamine and the
cardiodepressor effects of propofol is reached with the
combine use of both drugs (Guit et al. 1991, Hui et al.
1995, Lerche et al. 2000).
In our study cardiac index and cardiac output showed
stable values close to those of baseline and the peripheral
vascular resistance was stable in all groups. A slight
increase in the systolic arterial blood pressure was
observed in all groups. The slight increase in the systolic
arterial blood pressure at the time of ovarian pedicle
clamping (M4) and the significant increase in heart rate in
both groups at all time points, could be due to the stimulus
of the sympathetic nervous system induced by ketamine
and surgical procedure. In this study the new surgical
stimulus was performed 3 minutes after the bolus injection
of 20% of induction dose of propofol and the infusion rates
were increased by 20% over the previous value. Previous
studies have shown that the time required for plasmatic
concentration equilibrium between blood and brain was
12 minutes (Stuart et al. 2000).  In this view, we could
have waited more than 12 minutes for the new surgical
stimulus and recording of parameters.
In our study, the significant reduction of the systolic
index at all time points, in the two studied groups (PRK: -
50% in M2 and PSK: -45% in M5), is probably due to the
increase in heart rate and slight reduction of the cardiac
index during anaesthesia, considering that this parameters
are the result of the relationship between the cardiac index
and the heart rate (Shoemaker 1995).
The intense respiratory depression observed after
induction and at the beginning of drug infusion in both
groups, is in agreement with other studies (Claeys et al.
1988, Morgan & Legge 1989, Muir & Gadawski 1998). In
Table 4. Mean values and standard deviations of the recovery
times measured from the end of the infusion of propofol-
racemic ketamine (PRK) and propofol-S-ketamine (PSK)
Groups Tracheal Head Lift Sternal
extubation (minutes) tecumbency
(minutes) (minutes)
PRK 17.0±9.3 36.4±15.4 39.1±10.8
Propofol (mg kg-1 min-1)
PSK 10.7±8.9 31.2±14.3 35.1±6..2
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both groups, assisted ventilation was required for all
animals.  Spontaneous ventilation was restored within few
minutes after infusion interruption. The same condition was
observed by Schüttler et al. (1991) during anaesthesia with
continuous infusion of propofol and ketamine in humans.
Scarrone et al. (1990) observed a more pronounced
respiratory depression in patients treated with propofol
alone than in those treated with a combination of propofol
and ketamine. Nevertheless, in the present study, the
association of racemic ketamine and S-ketamine with
propofol did not reduce the occurrence of its negative
effects on the respiratory system, since ketamine is also a
respiratory depressant. Hui et al. (1995) also observed
respiratory depression with propofol/ racemic ketamine
combination, in human patients.
In our study, during TIVA, arterial pH was lower than
that reported in other studies in which propofol were used
for maintenance (Claeys et al. 1988, Scarrone et al. 1990).
This acidemia is probably due to the fact that our animals
were initially maintained on spontaneous ventilation and
only when the concentration values of expired carbon
dioxide reached 45mmHg, assisted ventilation was
introduced.
The use of lower doses of S-ketamine in the PSK group
may have influenced the faster recovery rate. Similar
findings have been demonstrated in humans (White et al.
1985; Adams et al. 1992; Doenicke et al. 1992b; Calvey
1995) and in horses undergoing total intravenous anes-
thesia with S(+) ketamine, romifidine and diazepam in
comparison with racemic ketamine, romifidine and
diazepam (Rossetti et al. 2008). During the recovery
period, there was a reestablishment in the haemodynamic
parameters due to lower concentrations of drugs in the
central nervous system. Some studies in humans have
shown that patients treated with equianaesthetic doses of
S(+) ketamine felt less fear, disorientation and pain in post-
operative period, and described more wellness and
happiness when compared with racemic ketamine (White
et al. 1980). These results may explain the faster recovery
rate in the PSK group.
In the present study there was a need of more propofol
supplementation in the PSK group. In this case, one can
question the two to four fold increase in anaesthetic and
analgesic potency of S(+)Ketamine in relation to racemic
ketamine (White et al. 1985, Mathisen et al. 1995, Lauretti
et al. 2000). Moreover, it is also possible that the doses of
propofol and/or both ketamines could be readjusted.
Alternatively, the use of an opioid analgesic in pre-
medication may reduce the required doses of propofol and
ketamine for the overall anaesthetic effect as well as to
reduce cardiovascular alterations.
CONCLUSION
The combination of propofol with S(+)ketamine and
propofol with racemic ketamine for induction and
maintenance of anaesthesia under TIVA has shown a good
haemodynamic stability in both groups. However, an
intense respiratory depression was also observed in which
case assisted ventilation was made necessary. Although
the effects of both associations were similar, the
combination of propofol with S(+)ketamine showed better
recovery, probably due to lower dose requirements. Further
studies are necessary to evaluate different approaches in
order to establish new protocols regarding the combine
use of propofol and ketamine.
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